ENZ Enzo Biochem Inc
Price (delayed)
$0.3325
Market cap
$17.42M
P/E Ratio
N/A
Dividend/share
$0.1
EPS
-$0.42
Enterprise value
-$19.81M
Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and intellectual property through the development of unique diagnostic platform technologies that provide numerous
Highlights
Enzo Biochem's debt has shrunk by 57% YoY and by 3.9% QoQ
Enzo Biochem's quick ratio has increased by 18% from the previous quarter
Enzo Biochem's net income has plunged by 165% YoY but it has increased by 7% from the previous quarter
The EPS has plunged by 163% YoY but it has grown by 7% from the previous quarter
ENZ's equity is down by 34% YoY and by 2.2% from the previous quarter
The company's revenue fell by 11% YoY and by 4% QoQ
Key stats
What are the main financial stats of ENZ
Market
Valuations
Earnings
Shares outstanding
52.4M
Market cap
$17.42M
Enterprise value
-$19.81M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.37
Price to sales (P/S)
0.6
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.68
Revenue
$29.1M
Gross profit
$13.02M
Operating income
-$9.93M
Net income
-$21.31M
EBIT
-$20.33M
EBITDA
-$18.96M
Free cash flow
-$15.75M
Per share
Balance sheet
Liquidity
EPS
-$0.42
EPS diluted
-$0.42
Free cash flow per share
-$0.3
Book value per share
$0.89
Revenue per share
$0.56
TBVPS
$1.29
Total assets
$67.51M
Total liabilities
$20.89M
Debt
$3.07M
Equity
$46.62M
Working capital
$35.04M
Debt to equity
0.07
Current ratio
3.04
Quick ratio
2.59
Net debt/EBITDA
1.96
Margins
Efficiency
Dividend
EBITDA margin
-65.2%
Gross margin
44.7%
Net margin
-73.2%
Operating margin
-34.1%
Return on assets
-26.5%
Return on equity
-38.9%
Return on invested capital
-164.6%
Return on capital employed
-40.4%
Return on sales
-69.9%
Dividend yield
30.08%
DPS
$0.1
Payout ratio
N/A
ENZ stock price
How has the Enzo Biochem stock price performed over time
Intraday
-2.21%
1 week
-24.43%
1 month
-30.87%
1 year
-74.02%
YTD
-53.45%
QTD
-10.14%
Financial performance
How have Enzo Biochem's revenue and profit performed over time
Revenue
$29.1M
Gross profit
$13.02M
Operating income
-$9.93M
Net income
-$21.31M
Gross margin
44.7%
Net margin
-73.2%
Enzo Biochem's net margin has shrunk by 174% YoY but it has increased by 2.8% QoQ
Enzo Biochem's net income has plunged by 165% YoY but it has increased by 7% from the previous quarter
The operating income has soared by 57% YoY and by 6% from the previous quarter
The operating margin has soared by 52% YoY
Growth
What is Enzo Biochem's growth rate over time
Valuation
What is Enzo Biochem stock price valuation
P/E
N/A
P/B
0.37
P/S
0.6
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.68
The EPS has plunged by 163% YoY but it has grown by 7% from the previous quarter
The P/B is 80% less than the 5-year quarterly average of 1.9 and 58% less than the last 4 quarters average of 0.9
ENZ's equity is down by 34% YoY and by 2.2% from the previous quarter
The P/S is 70% below the 5-year quarterly average of 2.0 and 62% below the last 4 quarters average of 1.6
The company's revenue fell by 11% YoY and by 4% QoQ
Efficiency
How efficient is Enzo Biochem business performance
ENZ's ROA has dropped by 181% year-on-year and by 2.7% since the previous quarter
ENZ's ROE has shrunk by 172% YoY and by 3.7% QoQ
The ROS has plunged by 171% YoY but it has grown by 4.9% from the previous quarter
The ROIC has contracted by 5% from the previous quarter
Dividends
What is ENZ's dividend history
DPS
$0.1
Dividend yield
30.08%
Payout ratio
N/A
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Enzo Biochem financials performed over time
ENZ's total assets is down by 32% year-on-year and by 10% since the previous quarter
The total liabilities has contracted by 26% YoY and by 24% from the previous quarter
Enzo Biochem's debt is 93% lower than its equity
Enzo Biochem's debt has shrunk by 57% YoY and by 3.9% QoQ
ENZ's equity is down by 34% YoY and by 2.2% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.